Angel Pond Holdings (NYSE:POND) announced this morning that it has closed its combination with MariaDB and its shares and warrants will begin trading on the NYSE today under the symbols “MRDB” and “MRDB WS”.
The press release notes that the SPAC’s shareholders approved the deal at a vote in November 22, but the company did not immediately announce the results of the meeting. In a subsequent 8-K on December 11, Angel Pond revealed that 99% of its shares were redeemed, removing about $262.9 million from its trust.
This left just 258,925 public shares shares remaining with the company, but deal was also supplemented with a $104 million PIPE made up of Series D preferred shares and an $18.2 million PIPE at $9.50 per share. This more than cleared the transaction’s $100 minimum cash condition.
Angel Pond inked its $672 million combination with MariaDB on February 1. Redwood City, California-based MariaDB provides an software platform for enterprise business and cloud management with about 1 billion downloads to date.
It expects to generate $47 million in revenue in 2022E for an operating loss of -$43.2 million.
ADVISORS
- Cleary Gottlieb Steen & Hamilton LLP, Hannes Snellman Attorneys Ltd, Arthur Cox and Maples Group are serving as legal advisors to Angel Pond.
- Perkins Coie LLP, Fondia, Matheson and Conyers are serving as legal advisors to MariaDB.
- J.P. Morgan Securities LLC and Angel Pond Capital LLC served as placement agents to Maria DB and Angel Pond in connection with the Series D Financing and PIPE offerings.
- J.P. Morgan Securities LLC is acting as capital markets advisors to Angel Pond.
Terms Tracker for the Week Ending March 31, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Filings continue to remain quiet, but SPACs did manage to price two more IPOs this week with TMT Acquisition Corp (Nasdaq: TMTCU) and Trailblazer Merger...
Hudson Acquisition I Corp. (NASDAQ:HUDA) announced that it has signed a non-binding letter of intent (LOI) to combine with a pre-clinical-stage biotechnology company. The SPAC did not provide many details on the unnamed target, but disclosed that the biotech company is focused on developing intranasal preventives for major disease-causing respiratory viruses. As a condition to the target...
Heading into April, SPACs are to see eight sponsors and 11 de-SPAC’d companies freed from lock-ups and ready to trade. Most of these lock-up expirations are loaded into the final week of the month, but those hitting this milestone already next week include some of the more interesting transactions of the crop. In particular, MoonLake...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Shares of Digital World jump after Trump’s indictment, and pair of Delaware Chancery court decisions deny motions to dismiss SPAC shareholder’s fiduciary breach claims Trump-Tied SPAC’s Shares Jump After Historic New York Charge The...
Ares Acquisition Corporation II (NYSE:AACT) filed its S-1 yesterday afternoon for a $400 million IPO, marking the second SPAC to file for an IPO in March and the largest since December 20, 2021, when Gores Holdings X Inc. filed for a $725 million SPAC. Ares II intends to focus its search on an established target...